Similarly, fisetin suppressed the protein levels of antiapoptotic Bcl-XL and BCL-2 and increased proapoptotic BAK and BIM in HCT-116 colon cancer cells (Lim & Park, 2009). Here, BCL2 is linked to malignant colon neoplasm.